Akira S, Takeda K, Kaisho T. Toll-like receptors：critical proteins linking innate and acquired immunity[J]. Nat Immunol, 2001, 2（8）：675-680.
[4]
Anderson KV. Toll signaling pathways in the innate immune response[J]. Curr Opin Immunol, 2000, 12（1）：13-19.
[5]
Takeda K, Kaisho T, Akira S. Toll-like receptors[J]. Annu Rev Immunol, 2003, 21：335-376.
[6]
Alexopoulou L, Holt AC, Medzhitov R, et al. Recognition of double-stranded RNA and activation of NF-kappaB by Toll-like receptor 3[J]. Nature, 2001, 413（6857）：732-738.
[7]
Matsumoto M, Kikkawa S, Kohase M, et al. Establishment of a monoclonal antibody against human Toll-like receptor 3 that blocks double-stranded RNA-mediated signaling[J]. Biochem Biophys Res Commun, 2002, 293（5）：1364-1369.
[8]
Kawai T, Akira S. Pathogen recognition with Toll-like receptors[J]. Current Opinion in Immunology, 2005, 17（4）：338-344.
[9]
Bell JK, Mullen GE, Leifer CA, et al. Leucine-rich repeats and pathogen recognition in Toll-like receptors[J]. Trends in Immunology, 2003, 24（10）：528-533.
[10]
Means TK, Golenbock DT, Fenton MJ. Structure and function of Toll-like receptor proteins[J]. Life Sci, 2000, 68（3）：241-258.
[11]
Kawai T, Akira S. The role of pattern-recognition receptors in innate immunity：update on Toll-like receptors[J]. Nat Immunol, 2010, 11（5）：373-384.
Le Goffic R, Balloy V, Lagranderie M, et al. Detrimental contribution of the Toll-like receptor（TLR）3 to influenza A virus-induced acute pneumonia[J]. PLoS Pathog, 2006, 2（6）：526-535.
